Skip to content

Clinical trials

Osteoporosis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Country / region: South Korea Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20061
20074
20082
20092
20101
20112
20122
20133
20151
20161
20176
20181
20192
20201
20211
20222
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Unknown status5
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Hanlim Pharm. Co., Ltd.3
Seoul National University Bundang Hospital3
Seoul National University Hospital3
Addpharma Inc.2
Amgen2
Eli Lilly and Company2
Hyundai Pharmaceutical Co., LTD.2
Ligand Pharmaceuticals2
Yonsei University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis38
Bone Diseases, Metabolic6
Osteoporosis, Postmenopausal3
Bone Diseases2
Fractures, Bone2
Musculoskeletal Diseases2
Arthritis1
Arthritis, Rheumatoid1
Asthma1
Bone Resorption1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.